Research graph
References from USF1 promotes growth and glycolysis in acute myeloid leukemia cells. Local targets link to admitted publications; unresolved targets remain external evidence.
Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic
10.1101/gad.349368.122 · 2022 · External reference
The clinical impact of the molecular landscape of acute myeloid leukemia
10.3324/haematol.2022.280801 · 2023 · External reference
Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia
10.1007/s00262-021-03111-2 · 2022 · External reference
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
10.1182/blood-2015-01-621870 · 2015 · External reference
Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets
10.1182/blood.2022018092 · 2023 · External reference
Endogenous retroelement activation by epigenetic therapy reverses the Warburg effect and elicits mitochondrial-mediated cancer cell death
10.1158/2159-8290.cd-20-1065 · 2021 · External reference
Acute myeloid leukemia mitochondria hydrolyze ATP to support oxidative metabolism and resist chemotherapy
10.1126/sciadv.adu5511 · 2025 · External reference
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia
10.1038/s41467-023-41229-2 · 2023 · External reference
R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m(6)A/PFKP/LDHB axis
10.1016/j.molcel.2020.12.026 · 2021 · External reference
Immune effects of PI3K/Akt/HIF-1alpha-regulated glycolysis in polymorphonuclear neutrophils during sepsis
10.1186/s13054-022-03893-6 · 2022 · External reference
Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis
10.1038/s41418-022-00971-8 · 2022 · External reference
mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma
10.7150/thno.72581 · 2022 · External reference
USF1/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion
10.1093/neuonc/noac063 · 2022 · External reference
Endothelial PTP4A1 mitigates vascular inflammation via USF1/A20 axis-mediated NF-kappaB inactivation
10.1093/cvr/cvac193 · 2023 · External reference
USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis
10.1136/gutjnl-2019-318640 · 2020 · External reference
USF1-ATRAP-PBX3 axis promote breast cancer glycolysis and malignant phenotype by activating AKT/mTOR signaling
10.7150/ijbs.69134 · 2022 · External reference
Immune escape and immunotherapy of acute myeloid leukemia
10.1172/jci129204 · 2020 · External reference
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia
10.1084/jem.20200924 · 2021 · External reference
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
10.1038/s41591-018-0233-1 · 2018 · External reference
Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway
10.1016/j.apsb.2024.07.004 · 2024 · External reference
USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1
10.1038/s41419-019-1516-2 · 2019 · External reference
Upregulation of superenhancer-driven LncRNA FASRL by USF1 promotes de novo fatty acid biosynthesis to exacerbate hepatocellular carcinoma
2022 · External reference
Functional interrogation of HOXA9 regulome in MLLr leukemia via reporter-based CRISPR/Cas9 screen
10.7554/elife.57858 · 2020 · External reference
USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes
10.1161/circresaha.122.321849 · 2023 · External reference
